Tochigi, Japan

Hitoshi Kozuka

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hitoshi Kozuka: Innovator in Aqueous Drug Formulations

Introduction

Hitoshi Kozuka is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aqueous drug formulations. With a total of 3 patents to his name, Kozuka's work focuses on enhancing the stability and efficacy of drug compounds.

Latest Patents

Kozuka's latest patents include innovative methods for producing aqueous drugs. One of his patents describes an aqueous drug that inhibits the chemical decomposition of specific compounds, ensuring their effectiveness. This aqueous drug consists of a solution that maintains a pH of 5.3 or less, mixed with a dilution liquid for administration. Another patent introduces a novel technique to suppress the chemical degradation of compounds in aqueous formulations, utilizing a magnesium compound to enhance stability.

Career Highlights

Kozuka is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research in drug formulation. His work has been instrumental in developing safer and more effective pharmaceutical products. His innovative approaches have garnered attention in the pharmaceutical industry, contributing to the advancement of drug delivery systems.

Collaborations

Kozuka collaborates with talented colleagues such as Takahiro Goto and Mizuho Shibata. Their combined expertise fosters a productive research environment, leading to groundbreaking developments in the field.

Conclusion

Hitoshi Kozuka's contributions to aqueous drug formulations highlight his role as an influential inventor in the pharmaceutical industry. His innovative patents and collaborative efforts continue to pave the way for advancements in drug stability and efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…